All the Active Ingredient Drugs
Selective Immunosuppressants. Abatacept 125 mg/ml, 250 mg. PRE-FILLED SYRINGE: 4 Syr (single dose)
125 mg SC inj. once wkly. W or w/o an
IV load. dose. Pts. transit. from IV ther.
to SC administ. 1st SC dose instead of
the next scheduled IV dose.
Reduct. signs and symp., inducing
major clinic. response, inhib. the
progress. of struct. damage, and
improve. phys. func. in adult pts. with
moderat. to severe. act. RA.
Used as monother.or concom. DMARDs
other than TNF antagonists.
VIAL (pwdr for conc. for infus.): 1x250mg. See lit.
As monotherapy for tmt. mod.-severe
active rheum. arthrit. in adults with
DMARDs other than TNF antagonists . A
reduct. in progress. joint damage and
improv. phys. funct. have been
demonstrat. In combinat. tmt. with abatacept and methotrexate. In
combinat.with methotrexate for tmt.
mod.-severe active polyarticul. juvenile
idiopathic arthrit. (JIA) in ped. pts 6 yrs of
age and older, with insuffic. response to
other DMARDs incl. at least one TNF
inhibitor. Has not been studied in child. <
6 yrs.
C/I: Should not be administered
concomitantly with TNF antagonists. Is
not recommended for use
concomitantly with other biologic
rheumatoid arthritis (RA) therapy.